Abstract

BackgroundOvarian cancer is one of the leading causes of cancer-related death in women. The incidence of ovarian cancer is insidious, and the recurrence rate is high. The survival rate of ovarian cancer has not significantly improved over the past decade. Recently, immune checkpoint inhibitors such as those targeting CTLA-4, PD-1, or PD-L1 have been used to treat ovarian cancer. Therefore, a full analysis of the immune biomarkers associated with this malignancy is necessary.MethodsIn this study, we used data from The Cancer Genome Atlas (TCGA) database to analyze the infiltration patterns of specific immune cell types in tumor samples. Data from the Gene Expression Omnibus (GEO) database was used for external validation. According to the invasion patterns of immune cells, we divided the ovarian cancer microenvironment into two clusters: A and B. These tumor microenvironment (TME) subtypes were associated with genomic and clinicopathological characteristics. Subsequently, a random forest classification model was established. Differential genomic features, functional enrichment, and DNA methylation were analyzed between the two clusters. The characteristics of immune cell infiltration and the expression of immune-related cytokines or markers were analyzed. Somatic mutation analysis was also performed between clusters A and B. Finally, multivariate Cox analysis was used to analyze independent prognostic factors.ResultsThe ovarian cancer TME cluster A was characterized by less infiltration of immune cells and sparse distribution and low expression of immunomodulators. In contrast, cytotoxic T cells and immunosuppressive cells were significantly increased in the ovarian cancer TME cluster B. Additionally, immune-related cytokines or markers, including IFN-γ and TNF-β, were also expressed in large quantities. In total, 35 differentially methylated and expressed genes (DMEGs) were identified. Functional enrichment analyses revealed that the DMEGs in cluster B participated in important biological processes and immune-related pathways. The mutation load in cluster B was insignificantly higher than that of cluster A (p = 0.076). Multivariate Cox analysis showed that TME was an independent prognostic factor for ovarian cancer (hazard ratio: 1.33, 95% confidence interval: 1.01–1.75, p = 0.041).ConclusionThis study described and classified basic information about the immune invasion pattern of ovarian cancer and integrated biomarkers related to different immunophenotypes to reveal interactions between ovarian cancer and the immune system.

Highlights

  • Epithelial ovarian cancer is the main pathological type of ovarian cancer, and it has some histological subtypes, such as such as ovarian clear cell carcinoma, mucinous ovarian cancer and serous ovarian cancer (Lowe et al, 2013)

  • This study described and classified basic information about the immune invasion pattern of ovarian cancer and integrated biomarkers related to different immunophenotypes to reveal interactions between ovarian cancer and the immune system

  • There were 343 patients from The Cancer Genome Atlas (TCGA) enrolled in the discovery cohort and 439 patients from the Gene Expression Omnibus (GEO) database enrolled in the validation cohort

Read more

Summary

Introduction

Epithelial ovarian cancer is the main pathological type of ovarian cancer, and it has some histological subtypes, such as such as ovarian clear cell carcinoma, mucinous ovarian cancer and serous ovarian cancer (Lowe et al, 2013). Recently, several researches have investigated the functions of immune cells and cytokines in the TME in tumor development and/or tumor immune escape These studies have reported new methods of evaluating the infiltration of immune cells or factors in the TME (Lorenzo-Sanz & Munoz, 2019). We used data from The Cancer Genome Atlas (TCGA) database to analyze the infiltration patterns of specific immune cell types in tumor samples. According to the invasion patterns of immune cells, we divided the ovarian cancer microenvironment into two clusters: A and B These tumor microenvironment (TME) subtypes were associated with genomic and clinicopathological characteristics. The ovarian cancer TME cluster A was characterized by less infiltration of immune cells and sparse distribution and low expression of immunomodulators.

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call